The National Ovarian Cancer Coalition's Team Teal is embarking on an extraordinary journey to take hope to new heights. On July 9, 2024, a team of ovarian cancer survivors, caregivers, and loved ones will begin their trek to the summit of Mount Kilimanjaro in Tanzania, Africa. This inspiring expedition aims to provide hope to those living with ovarian cancer, raise…

The National Ovarian Cancer Coalition (NOCC) proudly announces that CEO Melissa Aucoin has been named a finalist for D CEO’s 7th Annual Nonprofit and Corporate Citizenship Awards in the Leadership Excellence (Large) category. This year’s program attracted a record number of nominations—more than 800—demonstrating the depth and strength of the nonprofit community in North Texas and the deep engagement of…

The National Ovarian Cancer Coalition funded two Young Investigator Research Grants in partnership with the Foundation for Women's Cancer. The Young Investigator Award provides crucial support to researchers in the early stages of their careers, often when they have limited funding opportunities and resources.  By offering these awards, we aim to help move the needle in gynecologic cancer research.    The…

The overexpression of the gene, BRD4, may be the cause of chemotherapy resistance in patients with high-grade serous ovarian cancer, according to research.